Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma-Reference-Cited by-同舟云学术

Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma

Published:2021-03-21 Issue:9 Volume:62 Page:2141-2150
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Uryu Hideki¹^ORCID,Mishima Yuko¹,Tsuyama Naoko²,Yokoyama Masahiro¹,Nishimura Noriko¹,Fukuta Takanori¹,Shirouchi Yuko¹^ORCID,Okabe Takashi¹,Inoue Norihito¹²,Takeuchi Kengo²³,Terui Yasuhito¹

Affiliation:

1. Department of Hematology Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

2. Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

3. Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1901091

Reference33 articles.

1. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients.

2. Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma

3. Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma

4. Risk and Clinical Implications of Transformation of Follicular Lymphoma to Diffuse Large B-Cell Lymphoma

5. Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma;BioMed Research International;2022-05-24